119 related articles for article (PubMed ID: 1751200)
1. Evidence of mononuclear cell activation by hemodialysis.
Donati D; Degiannis D; Combates N; Raskova J; Raska K
ASAIO Trans; 1991; 37(3):M386-7. PubMed ID: 1751200
[TBL] [Abstract][Full Text] [Related]
2. Cytokine levels during hemodialysis.
Vaziri ND; Kaupke CJ; Yousefi S; Gonzales E; Cesario TC
ASAIO Trans; 1991; 37(3):M389-91. PubMed ID: 1751202
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 kinetics in hemodialysis.
Donati D; Degiannis D; Homer L; Raska K; Raskova J
ASAIO Trans; 1991; 37(3):M391-2. PubMed ID: 1751203
[TBL] [Abstract][Full Text] [Related]
4. Effects of hemodialysis on activation of lymphocytes: analysis by an in vitro dialysis model.
Donati D; Degiannis D; Combates N; Raskova J; Raska K
J Am Soc Nephrol; 1992 Apr; 2(10):1490-7. PubMed ID: 1600120
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of IL-2/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure.
Meier P; Dayer E; Ronco P; Blanc E
Clin Nephrol; 2005 Jan; 63(1):8-21. PubMed ID: 15678692
[TBL] [Abstract][Full Text] [Related]
6. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
[TBL] [Abstract][Full Text] [Related]
7. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.
Linnenweber S; Lonnemann G
Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027
[TBL] [Abstract][Full Text] [Related]
8. Chronic T-lymphocyte activation in chronic renal failure: a study of hemodialysis, CAPD and pre-dialysis patients.
Caruana RJ; Leffell MS; Lobel SA; Campbell HT; Cheek PL
Int J Artif Organs; 1992 Feb; 15(2):93-8. PubMed ID: 1555882
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 2-dependent immunoregulatory function in hemodialysis patients with chronic hepatitis C.
Garyfallos A; Raptopoulou-Gigi M; Orphanou H; Spaia S; Petridou P; Vayionas G
J Investig Allergol Clin Immunol; 1995; 5(5):255-8. PubMed ID: 8574431
[TBL] [Abstract][Full Text] [Related]
10. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.
Descamps-Latscha B; Herbelin A; Nguyen AT; Roux-Lombard P; Zingraff J; Moynot A; Verger C; Dahmane D; de Groote D; Jungers P
J Immunol; 1995 Jan; 154(2):882-92. PubMed ID: 7814891
[TBL] [Abstract][Full Text] [Related]
11. Analysis of regulation of T-cell responses by soluble inhibitory factors from the sera of patients with Hodgkin's disease.
Damle RN; Advani SH; Gangal SG
Int J Cancer; 1992 Jan; 50(2):192-6. PubMed ID: 1730512
[TBL] [Abstract][Full Text] [Related]
12. T cells activate the tumor necrosis factor-alpha system during hemodialysis, resulting in tachyphylaxis.
van Riemsdijk IC; Baan CC; Loonen EH; Knoop CJ; Navarro Betonico G; Niesters HG; Zietse R; Weimar W
Kidney Int; 2001 Mar; 59(3):883-92. PubMed ID: 11231343
[TBL] [Abstract][Full Text] [Related]
13. Hemodialysis related interleukin-2 receptor release by peripheral blood mononuclear cells.
Memoli B; Libetta C; De Nicola L; Rampino T; Capuano A; Guida B; Andreucci VE
ASAIO J; 1996; 42(1):60-3. PubMed ID: 8808460
[TBL] [Abstract][Full Text] [Related]
14. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
[TBL] [Abstract][Full Text] [Related]
15. T cells in patients undergoing chronic hemodialysis: mitogenic response, suppressor activity, and interleukin-2 production and receptor generation.
Raskova J; Ghobrial I; Shea SM; Ebert EC; Eisinger RP; Raska K
Diagn Immunol; 1986; 4(4):209-16. PubMed ID: 2944684
[TBL] [Abstract][Full Text] [Related]
16. [Effect of epimedium sagittatum on soluble IL-2 receptor and IL-6 levels in patients undergoing hemodialysis].
Chen X; Zhou M; Wang J
Zhonghua Nei Ke Za Zhi; 1995 Feb; 34(2):102-4. PubMed ID: 7796653
[TBL] [Abstract][Full Text] [Related]
17. Soluble interleukin-2 receptors in the serum of patients with chronic renal failure.
Takamatsu T; Yasuda N; Ohno T; Kanoh T; Uchino H; Fujisawa A
Tohoku J Exp Med; 1988 Aug; 155(4):343-7. PubMed ID: 3068834
[TBL] [Abstract][Full Text] [Related]
18. Complement activation in dialysis: effects on cytokines, lymphocyte activation and beta 2 microglobulin.
Gardinali M; Calcagno A; Conciato L; Agostoni A; Rosti A; Cori P; Vozzo N; Moroni A; Anelli A; Zoni U
Int J Artif Organs; 1994 Jun; 17(6):337-44. PubMed ID: 7806419
[TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin-2 receptors in chronic renal failure.
Hory B; Racadot E; Saint-Hillier Y; Peters A; Perol C
Am J Nephrol; 1991; 11(4):276-80. PubMed ID: 1799184
[TBL] [Abstract][Full Text] [Related]
20. Release of interleukin-6 and its soluble receptors by activated peripheral blood monocytes is elevated in hypocholesterolemic hemodialysis patients.
Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Alevyzaki F; Zoga M; Kyritsis I; Ioannou D; Fatourou A; Nicolaou C
Am J Nephrol; 2005; 25(5):484-90. PubMed ID: 16127269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
